Russian journal (Effektivnaya farmakoterapiya). 2010; 5(22): 36–7. (in Russian) tive effect of flow-cytometric evidence of leukemia in acute myeloid leukemia. <...> Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. <...> Baronciani D., Depau C., Targhetta C., Derudas D., Culurgioni F., Tandurella I., et al. <...> Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. <...> Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). <...> Greystoke B., Bonanomi S., Carr T.F., Gharib M., Khalid T., Coussons M., et al. <...> Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities. <...> European Society for Blood and Marrow Transplantation analysis of treosulfan conditioning before hematopoietic stem cell transplantation in children and adolescents with hematological malignancies. <...> Transplantations of allogenic and autologous hemopoietic stem cells in acute leukemia (results of 20-year experience). <...> Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies. <...> Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. <...> Treosulfan-based conditioning regimens for alloHSCT in children with acute lymphoblastic leukaemia. <...> Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. <...> ОТДАЛЕННАЯ НЕФРОТОКСИЧНОСТЬ ВЫСОКОДОЗНОЙ ХИМИОТЕРАПИИ ПО МОДИФИЦИРОВАННОЙ ПРОГРАММЕ NHL-BFM-90 У ВЗРОСЛЫХ БОЛЬНЫХ ДИФФУЗНОЙ В-КРУПНОКЛЕТОЧНОЙ ЛИМФОМОЙ ФГБУ «Гематологический научный центр» Минздрава России, 125167, г. <...> Москва, Россия Цель исследования – оценка отдаленной нефротоксичности высокодозной химиотерапии по модифицированной программе NHL-BFM-90 (mNHL-BFM-90) у взрослых больных диффузной В-крупноклеточной лимфомой (В-ККЛ). <...> В группу сравнения вошли 19 больных (8 мужчин и 11 женщин), получивших терапию по программе СНОР/R-СНОР в тот же период. <...> Медиана срока наблюдения после окончания лечения 6 <...>